The sub-boards play an important role in the German Breast Group. Members of these working groups develop innovative concepts and ideas for new study and research projects in cooperation with a large number of recognised German breast cancer experts. In addition, the sub-board members monitor the safety of trial participants over the course of each trial.
Our five sub-boards cover the principal scientific and clinical fields: within the German Breast Group, there are sub-boards specialising in adjuvant therapy, neoadjuvant therapy and metastatic breast cancer. Some years ago, we also set up two further sub-boards within the study group – one for locoregional and the other for translational research.
The role of the sub-boards is to examine whether proposed trials are relevant, feasible and fundable. In cases where the study concept meets these criteria, GBG Forschungs GmbH assumes responsibility for the planning, organisation and implementation of the trial. The corresponding sub-board members accompany the study project over its entire duration in their capacity as scientists.